# Severe Multifactorial Lactic Acidosis With Pulmonary Edema and Myocardial Injury in an Elderly Patient on Metformin Managed Conservatively: A Case Report

**Authors:** Kyaw Zin Aung, Ei Ei Cho, Su Su Htun, Nay Aung Zin, Thinn Thiri Soe, Han Thant Thant, Cherry Myint, Naw Eh Law Saw

PMC · DOI: 10.7759/cureus.102890 · 2026-02-03

## TL;DR

An elderly man with diabetes and kidney disease developed severe lactic acidosis and heart issues, but improved with conservative treatment instead of dialysis.

## Contribution

This case report demonstrates successful conservative management of severe lactic acidosis in an elderly patient without dialysis.

## Key findings

- The patient's lactic acidosis was caused by sepsis, kidney dysfunction, and metformin use.
- Conservative treatment led to normalization of acid-base balance, kidney function, and cardiac biomarkers.
- The case shows that individualized supportive care can be effective when dialysis is not an option.

## Abstract

Severe lactic acidosis is a life-threatening condition in elderly patients with multiple comorbidities. We report a 90-year-old man with type 2 diabetes mellitus (HbA1c 7.1%), hypertension, and chronic kidney disease (CKD) stage 3a (baseline estimated glomerular filtration rate (eGFR) of 56 mL/min/1.73 m²) who presented with acute dyspnea, orthopnea, and oliguria. Laboratory evaluation revealed metabolic acidaemia (pH 7.22), marked hyperlactatemia (8 mmol/L), and acute-on-chronic kidney injury. Clinical findings were consistent with acute pulmonary edema and myocardial injury, with elevated cardiac biomarkers but no ischemic electrocardiographic changes. Lactic acidosis was multifactorial, driven by sepsis from a diabetic foot infection, renal dysfunction, and metformin as a potential contributor. Initial management included intravenous sodium bicarbonate, loop diuretics, ventilatory support, and antimicrobial therapy. Renal replacement therapy was declined by the patient, and intensive conservative management with close biochemical and clinical monitoring was pursued. The patient gradually improved, with normalization of acid-base status, renal function, lactate, and cardiac biomarkers, allowing successful extubation and transition to oral therapy. This case highlights the diagnostic and therapeutic challenges of severe lactic acidosis in elderly patients with multiple comorbidities and demonstrates that individualized supportive care can lead to favorable outcomes even when standard interventions such as dialysis are not feasible.

## Linked entities

- **Chemicals:** metformin (PubChem CID 4091), sodium bicarbonate (PubChem CID 516892)
- **Diseases:** type 2 diabetes mellitus (MONDO:0005148), chronic kidney disease (MONDO:0005300), lactic acidosis (MONDO:0006040), pulmonary edema (MONDO:0006932)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, CMPK1 (cytidine/uridine monophosphate kinase 1) [NCBI Gene 51727] {aka CK, CMK, CMPK, UMK, UMP-CMPK, UMPK}
- **Diseases:** mitochondrial dysfunction (MESH:D028361), metabolic disturbance (MESH:D024821), critically ill (MESH:D016638), inflammatory (MESH:D007249), CKD (MESH:D051436), Pulmonary Edema (MESH:D011654), Lactic Acidosis (MESH:D000140), ischemic (MESH:D002545), diabetes (MESH:D003920), dyspnea (MESH:D004417), oliguria (MESH:D009846), motion abnormalities (MESH:D009041), acute-on-chronic kidney injury (MESH:D058186), chest pain (MESH:D002637), Myocardial Injury (MESH:D009202), tachycardia (MESH:D013610), arrhythmias (MESH:D001145), organ dysfunction (MESH:D009102), opacities (MESH:D003318), respiratory failure (MESH:D012131), diastolic dysfunction (MESH:D018487), hypoxemia (MESH:D000860), pericardial effusion (MESH:D010490), respiratory distress (MESH:D012128), fever (MESH:D005334), metabolic acidaemia (MESH:D008659), hypotension (MESH:D007022), hypokinesia (MESH:D018476), hypertension (MESH:D006973), diabetic foot infection (MESH:D017719), tachypnea (MESH:D059246), acid-base abnormalities (MESH:D000137), cough (MESH:D003371), cardiovascular dysfunction (MESH:D002318), acute organ dysfunction (MESH:D019965), infection (MESH:D007239), diabetic ketoacidosis (MESH:D016883), acidemia (MESH:C537358), sinus tachycardia (MESH:D013616), renal dysfunction (MESH:D007674), type 2 diabetes mellitus (MESH:D003924), left atrial enlargement (MESH:D059446), Sepsis (MESH:D018805), overdose (MESH:D062787), hyperlactatemia (MESH:D065906)
- **Chemicals:** oxygen (MESH:D010100), ketones (MESH:D007659), lactate (MESH:D019344), clindamycin (MESH:D002981), Metformin (MESH:D008687), Blood glucose (MESH:D001786), vildagliptin (MESH:D000077597), sodium bicarbonate (MESH:D017693), PaCO2 (-), HCO3 (MESH:D001639), Cr (MESH:D002857), ceftriaxone (MESH:D002443), furosemide (MESH:D005665), catecholamines (MESH:D002395), glycerin trinitrate (MESH:D005996), carbon dioxide (MESH:D002245), creatinine (MESH:D003404), alcohol (MESH:D000438)
- **Species:** Homo sapiens (human, species) [taxon 9606], Staphylococcus aureus (species) [taxon 1280]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12962037/full.md

---
Source: https://tomesphere.com/paper/PMC12962037